{"id":15407,"date":"2011-07-15T08:00:18","date_gmt":"2011-07-15T08:00:18","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=15407"},"modified":"2012-07-22T01:22:40","modified_gmt":"2012-07-22T01:22:40","slug":"htb-supplement-2011-pipeline-report-2","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/15407","title":{"rendered":"HTB supplement: 2011 pipeline report"},"content":{"rendered":"<h2>HIV, tuberculosis, and viral hepatitis: drugs, diagnostics, vaccines, immune-based therapies, and preventive technologies in development<\/h2>\n<p><a href=\"https:\/\/i-base.info\/htb\/15335\">Download 2011 pipeline report<\/a> PDF (1 MB)<\/p>\n<p>For the second year i-Base is partnering with Treatment Action Group (TAG) to produce a pipeline report on treatments for HIV (antiretrovirals, immune-based treatments and vaccines), hepatitis B and C and tuberculosis.<\/p>\n<p>This report also includes chapters on paediatric antiretrovirals, point of care diagnostics and treatment access.<\/p>\n<p>The publication is being launched at the IAS conference in Rome.<\/p>\n<p>The report is dedicated to Dr Robert Carr and David Kato Kisule.<\/p>\n<p>Sections include:<\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/15254\">Introduction and executive summary<\/a>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/15325\">Dedication<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15206\">Acknowledgments<\/a><\/li>\n<\/ul>\n<\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15247\">The antiretroviral pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15233\">The paediatric antiretroviral pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15231\">HIV point of care diagnostics pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15226\">Patents and the pipeline: is access under threat?<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15224\">Preventive technologies, immune-based and gene therapies, and research toward a cure<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15222\">The hepatitis C treatment pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15219\">The tuberculosis diagnostics pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15213\">The tuberculosis treatment pipeline<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/15209\">The tuberculosis vaccine pipeline<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>HIV, tuberculosis, and viral hepatitis: drugs, diagnostics, vaccines, immune-based therapies, and preventive technologies in development Download 2011 pipeline report PDF (1 MB) For the second year i-Base is partnering with Treatment Action Group (TAG) to produce a pipeline report on &hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-15407","post","type-post","status-publish","format-standard","hentry","category-editorial"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/15407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=15407"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/15407\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=15407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=15407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=15407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}